Abstract
Background: GAPDH is a glycolytic enzyme that aggregates during disease. Cysteine oxidation is the putative cause of aggregation. Whether GAPDH aggregation influences disease is unknown.
Results: Mutating Met-46 renders GAPDH resistant to free radical-induced aggregation.
Conclusion: Methionine oxidation, rather than cysteine oxidation, is a primary event that instigates GAPDH aggregation.
Significance: Mutating Met-46 in vivo should elucidate whether GAPDH aggregation causally contributes to disease.
Original language | English |
---|---|
Pages (from-to) | 26922-26936 |
Number of pages | 15 |
Journal | Journal of Biological Chemistry |
Volume | 289 |
Issue number | 39 |
DOIs | |
State | Published - 26 Sep 2014 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology